BANK OF AMERICA CORP /DE/ - ROCKET PHARMACEUTICALS INC ownership

ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 147 filers reported holding ROCKET PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of ROCKET PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$6,820,957
-20.5%
332,892
-22.9%
0.00%0.0%
Q2 2023$8,580,680
-18.8%
431,841
-30.0%
0.00%0.0%
Q1 2023$10,571,901
+39.5%
617,157
+59.4%
0.00%0.0%
Q4 2022$7,577,015
+167.6%
387,175
+118.3%
0.00%
Q3 2022$2,831,000
+198.6%
177,383
+157.4%
0.00%
Q2 2022$948,000
-41.2%
68,909
-32.2%
0.00%
Q1 2022$1,611,000
-27.9%
101,563
-0.8%
0.00%
Q4 2021$2,234,000
-62.2%
102,343
-48.3%
0.00%
-100.0%
Q3 2021$5,917,000
-62.5%
197,967
-44.4%
0.00%
-50.0%
Q2 2021$15,771,000
-32.9%
356,094
-32.8%
0.00%
-33.3%
Q1 2021$23,503,000
-24.3%
529,730
-6.4%
0.00%
-25.0%
Q4 2020$31,050,000
+103.0%
566,206
-15.4%
0.00%
+100.0%
Q3 2020$15,292,000
+63.8%
668,967
+50.0%
0.00%
+100.0%
Q2 2020$9,333,000
+132.9%
445,932
+55.3%
0.00%0.0%
Q1 2020$4,007,000
+836.2%
287,222
+1425.8%
0.00%
Q4 2019$428,000
-80.8%
18,824
-90.1%
0.00%
Q3 2019$2,224,000
+59.5%
190,824
+105.3%
0.00%
Q2 2019$1,394,000
+35.1%
92,936
+57.9%
0.00%
Q1 2019$1,032,000
+72.6%
58,870
+45.9%
0.00%
Q4 2018$598,000
-31.2%
40,360
+14.4%
0.00%
Q3 2018$869,000
+534.3%
35,271
+405.1%
0.00%
Q2 2018$137,000
-4.9%
6,983
-9.0%
0.00%
Q1 2018$144,0007,6730.00%
Other shareholders
ROCKET PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
RTW INVESTMENTS, LP 16,037,486$280,250,00019.13%
TANG CAPITAL MANAGEMENT LLC 2,965,485$52,015,0009.58%
Boxer Capital, LLC 1,466,051$25,715,0002.97%
Ghost Tree Capital, LLC 600,000$10,524,0002.75%
BRIDGER MANAGEMENT, LLC 1,529,032$26,819,0002.12%
Cormorant Asset Management, LP 1,700,000$29,818,0002.02%
EcoR1 Capital, LLC 450,000$7,893,0000.73%
UNIVERSITY OF NOTRE DAME DU LAC 171,015$3,000,0000.67%
Virtus ETF Advisers LLC 17,799$312,0000.66%
SPHERA FUNDS MANAGEMENT LTD. 290,001$5,087,0000.46%
View complete list of ROCKET PHARMACEUTICALS INC shareholders